Gene587
BCAT2: branched chain amino acid transaminase 2
Cite this record
ConductScience Library. BCAT2: branched chain amino acid transaminase 2. Genes, record 587. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/587
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O15382 | Branched-chain-amino-acid aminotransferase, mitochondrial | 392 | 30 | Ensembl, GeneID, HGNC |
Source UniProt
Patents54
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026063308 A | 2026-03-26 | 38 | O15382 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 39124 | O15382 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 5465 | O15382 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 5465 | O15382 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 5465 | O15382 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 9484 | O15382 | Espacenet |
| US 20240398993 A1 | 2024-12-05 | 19526 | O15382 | Espacenet |
| US 20240327476 A1 | 2024-10-03 | 39124 | O15382 | Espacenet |
| US 20230026259 A1 | 2023-01-26 | 9484 | O15382 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 9484 | O15382 | Espacenet |
NIH grants566
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BCAT2 papers | Newest fiscal year |
|---|---|---|---|
| P30DK020572 | Michigan Diabetes Research Center (MDRC) | 4 | 2025 |
| P01CA117969 | Genetics and Biology of Pancreatic Ductal Adenocarcinoma | 2 | 2025 |
| P30CA014051 | Cancer Center Support (Core) Grant | 2 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 2 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 2 | 2025 |
| P30DK056341 | Washington University Nutrition Obesity Research Center | 2 | 2025 |
| P50AA011999 | Southern California Research Center for ALPD and Cirrhosis | 2 | 2025 |
| P50CA221747 | SPORE for Translational Approaches to Brain Cancer | 2 | 2025 |
| R01AA005965 | CNS Deficits: Interaction of Age and Alcoholism | 2 | 2025 |
| R01DK097441 | Molecular mechanisms of UCP1-independent pathways in metabolic health | 2 | 2025 |
Source NIH's project files
Papers736
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metabolic-epigenetic coupling between leucine catabolism and glycolysis drives CDK4/6 inhibitor resistance. | bioRxiv | 2026 | 42818363 | PubTator, text mining | PubMed |
| Identification of key genes and mechanistic exploration of metabolic reprogramming in osteoporosis. | J Int Med Res | 2026 | 42805907 | PubTator, text mining | PubMed |
| Ferroptosis-related genes influence AML risk through immune cell-mediated pathways: a Mendelian randomization study with mediation analysis. | Blood Res | 2026 | 42766266 | PubTator, text mining | PubMed |
| A loss of the cytosolic branched-chain aminotransferase, BCATc, enhances Th1 differentiation and skews Tregs to acquire a Th1-like phenotype. | Immunometabolism (Cobham) | 2026 | 42445220 | PubTator, text mining | PubMed |
| Targeting the PARP10-BCAT2 axis disrupts branched-chain amino-acid metabolism to suppress bone metastasis in lung cancer. | Cell Death Dis | 2026 | 42321186 | PubTator, text mining | PubMed |
| Mitochondrial bioenergetic signatures differentiate asymptomatic from symptomatic Alzheimer's disease. | Commun Biol | 2026 | 42270947 | PubTator, text mining | PubMed |
| The emerging role of branched-chain amino acid metabolism in obesity. | Int J Obes (Lond) | 2026 | 42174220 | PubTator, text mining | PubMed |
| PARP1-BCAT2 axis upregulates ABCG1 via histone lactylation to drive acquired PARP inhibitor resistance in prostate cancer. | J Exp Clin Cancer Res | 2026 | 42108466 | PubTator, text mining | PubMed |
| Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies. | RSC Med Chem | 2026 | 42016580 | PubTator, text mining | PubMed |
| HucMSC-sEV-derived miR-320d alleviates IBD by inhibiting macrophage ferroptosis through m6A-mediated BCAT2 upregulation. | Bioorg Chem | 2026 | 41926795 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/587
GET https://conductscience.org/api/genes/v1/587/patents?page=2